© 2022 MJH Life Sciences and CGTLive™. All rights reserved.
© 2022 MJH Life Sciences™ and CGTLive™. All rights reserved.
May 19, 2010
At the 2010 Gastrointestinal Cancers Symposium, new data from the
CRYSTAL trial identified BRAF gene mutations as a poor prognostic indicator in metastatic colorectal cancer (mCRC) but not predictive of response to therapy.
March 15, 2010
NCCN included a dinner symposium on Maintenance Therapy for Non-Small Cell Lung Cancer.